The incidence of torsades de pointes with peri-operative low-dose ondansetron administration.

Gregory A NuttallSarah C VoogdHeather DankePaul A WarnerLance J OyenMary Shirk MarienauMichael J Ackerman

Published in: Pharmacotherapy (2022)

No episodes of TdP were identified in patients receiving ondansetron perioperatively. This suggests that low-dose ondansetron does not contribute to the development of TdP.

Keyphrases

low dose
chemotherapy induced
high dose
amyotrophic lateral sclerosis
risk factors
drug induced